These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26203291)

  • 1. Management options in decompensated cirrhosis.
    Shah NL; Banaei YP; Hojnowski KL; Cornella SL
    Hepat Med; 2015; 7():43-50. PubMed ID: 26203291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation and complications associated with cirrhosis of the liver.
    Poordad FF
    Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.
    Garcia-Tsao G; Lim JK;
    Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan.
    Ali B; Salim A; Alam A; Zuberi BF; Ali Z; Azam Z; Kamani L; Farooqi JI; Salih M; Nawaz AA; Chaudhry AA; Hashmi ZY; Siddique M
    Pak J Med Sci; 2020; 36(5):1117-1132. PubMed ID: 32704299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Liver Injury and Decompensated Cirrhosis.
    Crismale JF; Friedman SL
    Med Clin North Am; 2020 Jul; 104(4):647-662. PubMed ID: 32505258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Critically ill patients with decompensated liver cirrhosis - New aspects and intensive care management].
    Maschmeier M; Hüsing A; Schmidt H; Kabar I
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1514-6. PubMed ID: 26445254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.
    Nevens F; Bittencourt PL; Coenraad MJ; Ding H; Hou MC; Laterre PF; Mendizabal M; Ortiz-Olvera NX; Vorobioff JD; Zhang W; Angeli P
    Dig Dis Sci; 2019 Jun; 64(6):1419-1431. PubMed ID: 30684079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term albumin infusion in decompensated cirrhosis: A review of current literature.
    Wong YJ; Kumar R; Chua YJJ; Ang TL
    World J Hepatol; 2021 Apr; 13(4):421-432. PubMed ID: 33959225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of portal hypertension and its complications.
    Jaffe DL; Chung RT; Friedman LS
    Med Clin North Am; 1996 Sep; 80(5):1021-34. PubMed ID: 8804373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with decompensated cirrhosis.
    Harrison PM
    Clin Med (Lond); 2015 Apr; 15(2):201-3. PubMed ID: 25824076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status and perspectives of diagnosis and treatment of complications related to liver cirrhosis].
    Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):241-245. PubMed ID: 28494539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal Hypertension and Related Complications: Diagnosis and Management.
    Simonetto DA; Liu M; Kamath PS
    Mayo Clin Proc; 2019 Apr; 94(4):714-726. PubMed ID: 30947834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Developments in Hepatorenal Syndrome.
    Mindikoglu AL; Pappas SC
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):162-177.e1. PubMed ID: 28602971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal hypertension.
    Cárdenas A; Ginès P
    Curr Opin Gastroenterol; 2009 May; 25(3):195-201. PubMed ID: 19396956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of decompensated cirrhosis.
    Mansour D; McPherson S
    Clin Med (Lond); 2018 Apr; 18(Suppl 2):s60-s65. PubMed ID: 29700095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care.
    Philips CA; Kakkar K; Joseph M; Yerol PK; Ahamed R; Rajesh S; Augustine P
    J Clin Transl Hepatol; 2021 Aug; 9(4):576-586. PubMed ID: 34447688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
    De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
    World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.